A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate Treatment

Currently, infliximab is given for disease control for active rheumatoid arthritis (RA) patients despite methotrexate treatment. However, the efficacy and safety of infliximab in Korean patients has not been assessed appropriately. Therefore, we performed placebo-controlled, double-blind, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinhyun, Ryu, Heejung, Yoo, Dae-Hyun, Park, Sung-Hwan, Song, Gwan-Gyu, Park, Won, Cho, Chul-Soo, Song, Yeong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857365/
https://www.ncbi.nlm.nih.gov/pubmed/24339699
http://dx.doi.org/10.3346/jkms.2013.28.12.1716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857365/
https://www.ncbi.nlm.nih.gov/pubmed/24339699
http://dx.doi.org/10.3346/jkms.2013.28.12.1716

Ejemplares similares